Secondary lymphoedema after breast cancer surgery: A survival analysis

International Journal of Nursing Practice

Volumn 18, Issue 6, 2012, Pages 589-594

  Huang, Huaping ^a   Zhou, Jianrong ^a   Zeng, Qing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Lymphoedema; Nursing; Occurrence; Risk factors

Indexed keywords

ARTICLE; BODY MASS; BREAST TUMOR; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPHEDEMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

BODY MASS INDEX; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHEDEMA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84870285472     PISSN: 13227114     EISSN: 1440172X     Source Type: Journal    
DOI: 10.1111/ijn.12005     Document Type: Article

References (28)

1. Porter PL. Global trends in breast cancer incidence and mortality. Salud Publica De Mexico 2009; 51 (Suppl. 2): S141-S146.
2. American Cancer Society. Cancer Facts & Figures 2009. Atlanta, GA, USA: American Cancer Society, 2009.
3. Nielsen I, Gordon S, Selby A. Breast cancer related lymphoedema risk reduction advice: a challenge for health professionals. Cancer Treatment Reviews 2008; 34: 621-628.
4. Lawenda BD, Mondry TE, Johnstone PAS. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA: A Cancer Journal for Clinicians 2009; 59: 8-24.
5. Fu MR, Rosedale M. Breast cancer survivors' experiences of lymphoedema-related symptoms. Journal of Pain and Symptom Management 2009; 38: 849-859.
6. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa women's health study. Journal of Clinical Oncology 2008; 26: 5689-5696.
7. Mak SS, Mo KF, Suen JJS, Chan SL, Ma WL, Yeo W. Lymphedema and quality of life in Chinese women after treatment for breast cancer. European Journal of Oncology Nursing 2009; 13: 110-115.
8. Shih YCT, Xu Y, Cormier JN etal. Incidence, treatment costs, and complications of Lymphedema after breast cancer among women of working age: a 2-year follow up study. Journal of Clinical Oncology 2009; 27: 2007-2014.
9. Park JH, Lee WH, Chung HS. Incidence and risk factors of breast cancer lymphedema. Journal of Clinical Nursing 2008; 17: 1450-1459.
10. Langer I, Guller U, Berclaz G etal. Morbidity of sentinel lymph node Biopsy (SLN) alone versus SLN completion axillary lymph node dissection after breast cancer surgery. Annals of Surgery 2007; 245: 452-461.
11. Maughan KL, Lutterbie MA, Ham PS. Treatment of breast cancer. American Family Physician 2010; 81: 1339-1346.
12. Paskett ED, Naughton MJ, McCoy TP, Douglas Case L, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiology, Biomarkers & Prevention 2007; 16: 775-782.
13. Norman SA, Russell Localio A, Kallan MJ, Weber AL. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiology, Biomarkers & Prevention 2010; 19: 2734-2746.
14. Paskett ED. Breast cancer- related lymphedema: attention to a significant problem resulting from cancer diagnosis. Journal of Clinical Oncology 2008; 26: 5666-5667.
15. Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphedema secondary to breast cancer treatment. Annals of Oncology 2007; 18: 639-646.
16. Norman SA, Miller LT, Bernadette Erikson H, Frank Norman M, McCorkle R. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Physical Therapy 2001; 81: 1192-1205.
17. Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The memorial symptom assessment scale short form (MSAS-SF): validity and reliability. Cancer 2000; 89: 1162-1171.
18. Hayes S, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology 2008; 41: 18-28.
19. Deltombe T, Jamart J, Recloux S etal. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology 2007; 40: 26-34.
20. Armer JM, Elise Radina M, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nursing Research 2003; 52: 370-379.
21. Perterk JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92: 1368-1377.
22. Armer JM, Stewart BR, Shook RP. 30-month post-breast cancer treatment lymphoedema. Journal of Lymphoedema 2009; 4 14-18.
23. Norman SA, Russell Localio A, Potashnik SL etal. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. Journal of Clinical Oncology 2009; 27: 390-397.
24. Helms RL, O'hea EL, Corso M. Body image issues in women with breast cancer. Psychology, Health & Medicine 2008; 13: 313-325.
25. Vignes S, Arrault M, Dupuy A. Factors associated with increased breast cancer related lymphoedema volume. Acta Oncologica 2007; 46: 1138-1142.
26. Swenson KK, Nissen MJ, Leach JW, Post-White J. Case control study to evaluate predictors of lymphedema after breast cancer surgery. Oncology Nursing Forum 2009; 36: 185-193.
27. Shaw C, Mortimer P, Judd PA. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 2007; 110: 1868-1874.
28. Kaufmann M, Hortobagyi GH, Goldhirsch A, Scholl S, Markis A etal. Recommendations from an international expert panel on the use of primary systematic treatment of operable breast cancer: an update. Journal of Clinical Oncology 2008; 24: 1940-1949.